Therapy for extensive cutaneous injuries involving deep epithelial layers remains one of the most challenging problems in regenerative medicine due to the low intrinsic regenerative capacity of these tissues [1]. According to WHO data, over the past two years approximately 18% of all recorded visits to medical facilities were for superficial skin injuries, representing a 4.8% increase compared with 2018 [2]. Inpatient treatment of skin injuries is primarily based on local pharmacotherapy using topical agents in combination with protective dressings. These approaches are invasive and are associated with high risks of secondary infection, trauma to burn edges, and delayed regenerative processes, thereby promoting pathological scarring of tissues [3-4]. The development of foam-based aerosol drug formulations on a biopolymeric matrix can reduce the risks associated with invasive therapies by forming an atraumatic wound covering with high regenerative potential through inclusion of liposomal components loaded with a therapeutic agent [5].
The objective of this study was to justify physico-chemical approaches and select formation conditions for shape-retaining, foam-based, liposome-filled therapeutic compositions intended for targeted treatment of deep superficial epithelial defects, and to investigate the properties of the resulting composition.
We selected and characterized compositions based on foaming protein components and phospholipid liposomal inclusions containing quercetin. Using viscometry, potentiometry, and UV–visible spectrophotometry, we determined optimal concentrations of the constituents required for effective formation of a stable foamed structure under pressurized CO2 conditions, followed by generation of an atraumatic coating. It was found that foams incorporating liposomal components loaded with a therapeutic agent produced more uniform and twice-as-stable foam structures compared with systems containing only aqueous solutions of the components. Scanning electron microscopy (SEM) analysis of the lyophilized cryostructured foam phase revealed an average pore size of approximately 251 nm and characterized its distribution. Assessment of cytotoxicity and hemolytic activity confirmed the biocompatibility of the systems. Furthermore, we demonstrated that varying liposome membrane size and composition significantly affects encapsulation efficiency and the prolonged-release profile of the therapeutic agent.
In summary, we identified optimal colloid-chemical and technological parameters for preparing foam-forming biopolymeric formulations that incorporate liposomal components and a therapeutic compound, intended for treatment of extensive deep skin lesions. The efficacy and bioactivity of the developed compositions were confirmed in vitro.
References
[1] Siu W.S. Review on Current Advancements in Facilitation of Burn Wound Healing // Bioengineering. 2025. V. 12. P. 428.
[2] Sen C.K. Human Wound and Its Burden: Updated 2025 Compendium of Estimates // Adv Wound Care (New Rochelle). 2025. V. 14 № 9. P. 429-438.
[3] Han G., Ceilley R. Chronic wound healing: a review of current management and treatments //Advances in therapy. 2017. V. 34. № 3. P. 599-610.
[4] Foam-based drug delivery: A newer approach for pharmaceutical dosage form / M. Kumar, A. Thakur, U.K. Mandal et al. // AAPS PharmSciTech. 2022. Vol. 23. P. 244.
[5] Liposome-based drug delivery systems for skin wound healing: A promising drug delivery strategy / Z. Ma, K. Zhang, J. Luo et al. //Frontiers in Bioengineering and Biotechnology. 2026. V. 14. P. 1756872.